In immunologically inactive BC, it has been observed that the downregulation of TGF-β in stromal fibroblasts can lead to an upregulation of CXCL1, which then activates STAT3 by acting on CXCR2 in tumor cells [86]. The gene discussed is TGFB1; the disease is breast cancer.